Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference
Portfolio Pulse from
Aclarion, Inc. will showcase its NOCISCAN technology at the Selby Spine Conference. This technology combines MR Spectroscopy and AI to identify discogenic pain sources, potentially setting a new standard in chronic low back pain diagnosis.
January 31, 2025 | 5:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aclarion, Inc. is set to present its NOCISCAN technology at the Selby Spine Conference. This could position the company as a leader in diagnosing discogenic pain, potentially boosting its market presence.
The presentation of NOCISCAN at a major conference highlights Aclarion's innovative approach in healthcare technology. This exposure could enhance the company's reputation and attract interest from the medical community, potentially leading to increased adoption of its technology and a positive impact on its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100